AI-Driven Raw Material Management in Vaccine Production
The Journal of Business and Artificial Intelligence · 30.12.2024 · 1 (2)
DOI: 10.66241/7in1h ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Business and Artificial Intelligence, online erschienen am 30.12.2024. Verfasst von Reza Farahani.
Abstract (Originalsprache)
This case study explores the collaboration between Katalyze AI and a top-10 global biopharmaceutical company to develop a state-of the-art AI-enabled analytics platform for their vaccine production. Using an AI-enabled platform, the project digitized raw material data, applied predictive analytics, and introduced real-time monitoring to improve process efficiency. The initiative has already increased production yield by 3-5% and is on track to save $10 million annually per site by reducing deviations and root-cause analysis time. This project demonstrated AI's transformative potential in biomanufacturing, providing a scalable solution for enhanced product quality and supply chain reliability.
Zitieren
APA
Farahani, R. (2024). AI-Driven Raw Material Management in Vaccine Production. The Journal of Business and Artificial Intelligence, 1(2). https://doi.org/10.66241/7in1h
Vancouver
Farahani R. AI-Driven Raw Material Management in Vaccine Production. The Journal of Business and Artificial Intelligence. 2024;1(2). doi:10.66241/7in1h
BibTeX
@article{Farahani2024,
author = {Farahani, Reza},
title = {AI-Driven Raw Material Management in Vaccine Production},
journal = {The Journal of Business and Artificial Intelligence},
year = {2024},
volume = {1},
number = {2},
doi = {10.66241/7in1h}
}
EUVIMED